These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19021075)

  • 1. Cognitive changes in asymptomatic drug-naïve human immunodeficiency virus type 1 clade C infection.
    Gopukumar K; Rao SL; Satishchandra P; Dasgupta J; Ellis RJ; Subbakrishna DK; Mariamma P; Kamat A; Desai A; Ravi V; Rao BS; Satish KS; Kumar M
    J Neurovirol; 2008 Nov; 14(6):480-5. PubMed ID: 19021075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.
    Gupta JD; Satishchandra P; Gopukumar K; Wilkie F; Waldrop-Valverde D; Ellis R; Ownby R; Subbakrishna DK; Desai A; Kamat A; Ravi V; Rao BS; Satish KS; Kumar M
    J Neurovirol; 2007 Jun; 13(3):195-202. PubMed ID: 17613709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus.
    Yepthomi T; Paul R; Vallabhaneni S; Kumarasamy N; Tate DF; Solomon S; Flanigan T
    J Int Neuropsychol Soc; 2006 May; 12(3):424-30. PubMed ID: 16903135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
    Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
    Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in cognitive function among people with HIV-1 clade C infection in Northern India.
    Sharma A; Mohanty M; Salan T; Aggarwal D; Mandell L; Jones DL; Arheart K; Sharma A; Vyas S; Singh P; Govind V; Kumar M
    J Neurovirol; 2023 Oct; 29(5):614-625. PubMed ID: 37698788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men.
    Sahakian BJ; Elliott R; Low N; Mehta M; Clark RT; Pozniak AL
    Psychol Med; 1995 Nov; 25(6):1233-46. PubMed ID: 8637953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.
    Sun B; Abadjian L; Rempel H; Calosing C; Rothlind J; Pulliam L
    J Neurovirol; 2010 Mar; 16(2):115-24. PubMed ID: 20307252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.
    Paul RH; Joska JA; Woods C; Seedat S; Engelbrecht S; Hoare J; Heaps J; Valcour V; Ances B; Baker LM; Salminen LE; Stein DJ
    J Neurovirol; 2014 Dec; 20(6):627-35. PubMed ID: 25366660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.
    McCombe JA; Vivithanaporn P; Gill MJ; Power C
    HIV Med; 2013 Feb; 14(2):99-107. PubMed ID: 22994556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV clades B and C are associated with reduced brain volumetrics.
    Ortega M; Heaps JM; Joska J; Vaida F; Seedat S; Stein DJ; Paul R; Ances BM
    J Neurovirol; 2013 Oct; 19(5):479-87. PubMed ID: 24078556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological performance in patients with asymptomatic HIV-1 infection.
    Martínez-Banfi M; Vélez JI; Perea MV; García R; Puentes-Rozo PJ; Mebarak Chams M; Ladera V
    AIDS Care; 2018 May; 30(5):623-633. PubMed ID: 29411628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.
    Concha M; Graham NM; Muñoz A; Vlahov D; Royal W; Updike M; Nance-Sproson T; Selnes OA; McArthur JC
    Am J Epidemiol; 1992 Dec; 136(11):1338-48. PubMed ID: 1362630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune function and neuropsychological performance in HIV-1-infected homosexual men.
    Boccellari AA; Dilley JW; Chambers DB; Yingling CD; Tauber MA; Moss AR; Osmond DH
    J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):592-601. PubMed ID: 8098751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients.
    Ciccarelli N; Grima P; Fabbiani M; Baldonero E; Borghetti A; Milanini B; Limiti S; Colafigli M; Tamburrini E; Cauda R; De Luca A; Di Giambenedetto S
    Antivir Ther; 2015; 20(4):433-40. PubMed ID: 25504667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function in HIV-seropositive Nigerians without AIDS.
    Salawu FK; Bwala SA; Wakil MA; Bani B; Bukbuk DN; Kida I
    J Neurol Sci; 2008 Apr; 267(1-2):142-6. PubMed ID: 18001772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
    Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Kumar M
    J Neurovirol; 2009 Jan; 15(1):25-35. PubMed ID: 19031329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus.
    Guevara-Silva EA
    Neurologia; 2014 May; 29(4):224-9. PubMed ID: 23972623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.